Attorney General Jeffrey S. Chiesa

GSK agrees to pay $90 million to settle diabetes drug allegations

By

GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.

Newsletter